Insightful Word
  • Investing
  • Stock
  • Economy
  • Politics
  • Investing
  • Stock
  • Economy
  • Politics
No Result
View All Result
Insightful Word
No Result
View All Result
Home Stock

Novartis CEO ‘very confident’ on sales target, doesn’t fear patent cliff – newspaper

admin by admin
November 2, 2024
in Stock
0
Novartis CEO ‘very confident’ on sales target, doesn’t fear patent cliff – newspaper
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

ZURICH (Reuters) – Novartis (SIX:NOVN) expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an interview on Saturday, with the pharmaceuticals giant having nothing to fear from the end of patent protection on some drugs.

“I am very confident that we will achieve average growth of at least 5% per year until 2028,” Narasimhan told Swiss newspaper Finanz und Wirtschaft.

This would be made possible by eight or nine drugs with multi-billion dollar sales, he told the newspaper, although a big challenge will be maintaining the pipeline of new medications.

Narasimhan said he was confident the company would reach its growth target despite the imminent expiry of patents on some medications including Entresto used to treat heart failure.

“We also expect sales and profit growth for 2025. We will announce a specific forecast in January,” said Narasimhan, who has led Novartis since 2018.

“In the past, the expiry of major patents in our industry has often led to declining sales, but this is not to be feared at Novartis.”

The company will not, however, increase its core operating profit margin much beyond the current level of 40.1%, Narasimhan said.

“I consider a margin in the low 40% range to be sufficient – higher margins are generally not rewarded in the pharmaceutical industry as they come at the expense of investments in research, development and sales growth,” he said.

Novartis will also consider acquisitions, with a focus on bolt-on deals worth less than $1 billion.

“Of course, we will continue to look for deals of up to $10 billion or more,” Narasimhan said. “However, our analysis shows that the track record of such deals in the sector has historically been rather poor.”

This post appeared first on investing.com

Previous Post

How to navigate potential investment opportunities in China e-commerce sector

Next Post

LATAM crypto update: Argentina advances token regulations, Brazil’s crypto imports surge 40%

admin

admin

Next Post
LATAM crypto update: Argentina advances token regulations, Brazil’s crypto imports surge 40%

LATAM crypto update: Argentina advances token regulations, Brazil’s crypto imports surge 40%

Trending News

Novo Nordisk stock downgraded as Trump teases 250% pharma tariffs

Novo Nordisk stock downgraded as Trump teases 250% pharma tariffs

August 5, 2025
Financial Pro From Wall Street Sees XYZVerse Beating ONDO and PI Network With 15,000% Upside

Financial Pro From Wall Street Sees XYZVerse Beating ONDO and PI Network With 15,000% Upside

July 20, 2025
Could XRP Reach $20? Experts Think So—But XYZVerse Presale May Bring 50× Gains

Could XRP Reach $20? Experts Think So—But XYZVerse Presale May Bring 50× Gains

July 18, 2025
Subscribe to Insightful Word


    Recent News

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    August 7, 2025
    Affirm stock price is rising: is it a buy before earnings?

    Affirm stock price is rising: is it a buy before earnings?

    August 7, 2025
    Intel stock plunges sharply after Trump calls on CEO to resign: here’s why rebound may take time

    Intel stock plunges sharply after Trump calls on CEO to resign: here’s why rebound may take time

    August 7, 2025
    Goldman Sachs boosts Nvidia price target to $200 ahead of Q2 earnings

    Goldman Sachs boosts Nvidia price target to $200 ahead of Q2 earnings

    August 7, 2025

    Recent News

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    August 7, 2025
    Affirm stock price is rising: is it a buy before earnings?

    Affirm stock price is rising: is it a buy before earnings?

    August 7, 2025

    Latest News

    • Dow futures soar 250 points today: 5 things to know before Wall Street opens
    • Affirm stock price is rising: is it a buy before earnings?
    • Intel stock plunges sharply after Trump calls on CEO to resign: here’s why rebound may take time

    About Insightful Word

    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools
    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools

    Copyright © 2025 Insightfulword.com. All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Politics

    Copyright © 2025 Insightfulword.com. All Rights Reserved.